Dimethyl Fumarate

NAD(P)H quinone dehydrogenase 1 ; Homo sapiens







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33803289 Dimethyl Fumarate, an Approved Multiple Sclerosis Treatment, Reduces Brain Oxidative Stress in SIV-Infected Rhesus Macaques: Potential Therapeutic Repurposing for HIV Neuroprotection. 2021 Mar 9 1
2 33922540 Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis. 2021 Apr 23 2
3 34426902 Dimethyl fumarate prevents cytotoxicity and apoptosis mediated by oxidative stress in human adipose-derived mesenchymal stem cells. 2021 Sep 1
4 29928650 The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis. 2018 Jun 2
5 28156185 Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies. 2017 Dec 3
6 25009787 Dimethylfumarate attenuates restenosis after acute vascular injury by cell-specific and Nrf2-dependent mechanisms. 2014 5
7 24076006 Effects of fumaric acid esters on blood-brain barrier tight junction proteins. 2013 Oct 25 2
8 15655414 Enhanced cytotoxicity of bioreductive antitumor agents with dimethyl fumarate in human glioblastoma cells. 2005 Feb 1
9 15877230 Effect of NQO1 induction on the antitumor activity of RH1 in human tumors in vitro and in vivo. 2005 Sep 1
10 15467770 Dietary induction of NQO1 increases the antitumour activity of mitomycin C in human colon tumours in vivo. 2004 Oct 18 2
11 10376975 Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase. 1999 Jun 1